Please share with anyone who may be interested in joining this lawsuit.
According to the firm’s investigation, SkinMedica’s TNS products, which have been sold nationally through doctors’ offices and retailers, contain a proprietary mix of “human growth factors” derived from human foreskin tissue. Human growth factors are intended to mobilize, stimulate, or otherwise alter the production of cells, including the ability to initiate cell division, which could stimulate growth of cancerous tumor cells, according to the complaint.
The lawsuit is a proposed class action based upon California’s consumer protection laws, and seeks to represent a class of all persons in the U.S. who purchased SkinMedica’s TNS products during the last four years.
"Allergan Can't Duck Class Action Over Cream Cancer Risks" 8 September 2014.
In an order mostly denying the defendants’ motion to dismiss, U.S. District Judge David O. Carter ruled plaintiff Josette Ruhnke’s complaint sufficiently alleged that the sale of SkinMedica Inc.’s line of “Tissue Nutrient Solution” products containing the compound “NouriCel”...
"Plaintiffs Seek Cert. in SkinMedica Skin Cream Class Action Lawsuit" 14 May 2015.
Plaintiffs Josette Ruhnke and Cindy Verity asked a federal judge to grant them certification for a nationwide Class that would include all consumers who purchased products from SkinMedica’s Tissue Nutrient Solution line from March 2010 to present.
Additionally, the plaintiffs also reasserted before the California court that the SkinMedica skin cream products fall under the FDA’s definition of drugs and cosmetics.
|california , Circumcision|